Intellia Therapeutics Inc buy Citizens Jmp
Start price
06.10.25
/
50%
€17.99
Target price
06.10.26
€28.15
Performance (%)
-29.24%
Price
14:54
€12.73
Summary
This prediction is currently active. The price of Intellia Therapeutics Inc has decreased since the start of the prediction. Compared to the start price this results in a performance of -29.24%. This prediction currently runs until 06.10.26. The prediction end date can be changed by Citizens_Jmp at any time. Citizens_Jmp has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Intellia Therapeutics Inc | 18.345% | 18.345% |
| iShares Core DAX® | -1,31 % | -0,78 % |
| iShares Nasdaq 100 | 1,98 % | -2,04 % |
| iShares Nikkei 225® | 0,59 % | 6,71 % |
| iShares S&P 500 | 1,42 % | -0,48 % |
Comments by Citizens_Jmp for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics (NASDAQ:NTLA) was upgraded by analysts at Citizens Jmp from a "market perform" rating to an "outperform" rating. They now have a $33.00 price target on the stock.
Ratings data for NTLA provided by MarketBeat

